An add-on digital stereotaxy option for GE’s Senographe Essential lets users perform biopsies on its full-field digital mammography system, sparing institutions the expense of setting up a dedicated biopsy room, according to the company.
An add-on digital stereotaxy option for GE’s Senographe Essential lets users perform biopsies on its full-field digital mammography system, sparing institutions the expense of setting up a dedicated biopsy room, according to the company. GE Healthcare unveiled Senographe Essential Interventional as part of its digital mammography platform during the RSNA 2008. The biopsy feature leverages the FFDM detector to allow easy localization of lesions biopsy, making workflow more efficient and boosting productivity.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.